Since Abdera Therapeutics was founded in 2020, it has participated in 3 rounds of funding. In total Abdera Therapeutics has raised $150.5M. Abdera Therapeutics' last funding round was on Apr 2023 for a total of $110.0M.
Abdera Therapeutics has 7 investors, including venBio Partners, Viking Global Investors and Qiming Venture Partners USA. The latest investment occurred in Apr 2023.